RecruitingRecruiting
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
NCT06726590 · Texas A&M University
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
The Texas Interprofessional Pharmacogenomics Registry and Repository
About this study
This study wants to understand how genes can affect how the body responds to medicines. This information will help us determine whether changing your medicine can make you healthier and improve your life. We will study your medical history for the last year and the next five years after you join the study.
study goals include:
* Enrolling patients who take multiple medications or have harmful side effects from their medications.
* Keeping all medical information and genetic samples from patients in one place.
* Helping doctors make better decisions about which medicines to prescribe.
* Influencing insurance companies and the government to help pay for this kind of medical care for people who need to change their medicine to stay healthy.
Eligibility criteria
Inclusion Criteria:
* The study will invite patients who are eligible for PGX workup/PGX care to participate, provided they meet the following criteria: Use of five or more medications, including over the counter drugs, supplements, natural products, cannabis products, or other recreational drugs, or
* Individuals taking blood pressure or depression medications, even if less than five medications.
* Ability to understand and give consent.
* Able to consent to donate blood and/or urine samples and buccal swabs.
* Able to answer detailed questionnaires, including quarterly questionnaires about ADRs, cognitive testing such as serial mini-mental status exams, and or quality of life questions.
* Able to understand that their health record and changes in health status will be followed for a five-year period and shared in deidentified form with the research community.
* All genders.
* Any age over 18 years.
Exclusion Criteria:
* Individuals admitted to hospice.
* Declines to participate or interact with staff/share their medical status.
* A diagnosis of Alzheimer's disease or related dementias in a medical record as this indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning.,
* Individuals who are unable or unwilling to provide consent.
* Unable to verbally communicate and comprehend English language
Study design
Enrollment target: 3000 participants
Age groups: adult, older_adult
Timeline
Starts: 2025-11
Estimated completion: 2029-11
Last updated: 2025-09-12
Primary outcomes
- • Frequency and nature of ADRs on the Naranjo Scale (5 years)
Sponsor
Texas A&M University · other
Contacts & investigators
ContactKenneth S Ramos, MD, PhD · contact · kramos@tamu.edu · (713) 677-7440
ContactRick Silva, PhD · contact · ricksilva@tamu.edu
All locations (1)
Texas A&M Family CareRecruiting
Bryan, Texas, United States